
Jessica Rosenworcel, the Chairwoman of the Federal Communications Commission (FCC) and the first woman to be confirmed for the role, has announced her resignation. In a statement reflecting on her tenure, Rosenworcel called her service at the FCC “the honor of a lifetime,” particularly her time as chair, which marked a historic milestone for the agency.
Rosenworcel expressed gratitude to President Biden for appointing her to lead the agency, emphasizing the significance of the FCC’s role in shaping the nation’s digital landscape. She highlighted how her time in office coincided with a transformative period in communications, especially during the COVID-19 pandemic when technology became essential to both civic and commercial life.
Read more: FCC Opens Inquiry into Telecom Data Caps
“Taking the oath of office on the street outside of the agency during the height of the pandemic, when so much of our day-to-day moved online, made clear how important the work of the FCC is,” she stated. Rosenworcel also underscored the necessity of building a digital future that benefits everyone, a theme that defined her leadership at the FCC.
During her tenure, Rosenworcel championed issues such as expanding broadband access, addressing the digital divide, and promoting net neutrality. Her efforts often focused on ensuring that underserved communities had equitable access to communication technologies, a mission she pursued amid rapid technological advancements and challenges.
Source: TV Technology
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas